publication date: Sep. 1, 2017

NCI requests $591 million in additional funding for FY19

By Matthew Bin Han Ong

NCI is asking for $6.38 billion for fiscal year 2019­—nearly $1 billion, or 12 percent, above FY17 appropriation levels—to fully fund promising research areas.

The institute’s FY19 professional judgment budget proposal, also known as the Bypass Budget, is a unique authority established by the National Cancer Act of 1971.

That law designates the NCI director as the top official of the National Cancer Program, requiring this official to inform the U.S. president about opportunities in the cancer program. At least on paper, the document bypasses NIH and HHS, and goes directly to the White House.

The $591 million increase requested in the FY19 bypass budget consists of a $301 million inflation adjustment and $290 million in additional funding for research in seven areas. The proposed budget also includes $400 million in funding for the Cancer Moonshot initiative.

NCI Acting Director Douglas Lowy said NCI is thankful for “strong national support” for the biomedical research that the institute funds.

“The FY 2019 Budget Proposal is a unique opportunity for us to communicate to the President and Congress our best professional judgment about scientific opportunities to accelerate progress against cancer and the resources required to pursue this work,” Lowy wrote in an email Aug. 8 to NCI staff. “Presented each fiscal year, as required by … Continue reading NCI requests $591 million in additional funding for FY19

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.